| Patient Traits |
Non-MVT Users (%) |
MVT Use (%) |
p-value |
| Gender |
M: 61 |
M: 49 |
0.15 |
| F:39 |
F: 51 |
| Age |
<70: 77.8 |
<70: 62.3 |
0.03 |
| ≥70:22.2 |
≥70: 37.7 |
| KPS≥80 |
85.5 |
78.7 |
0.31 |
| Diabetes |
12.8 |
8.2 |
0.5 |
| Cardiovascular Disease |
11.1 |
14.8 |
0.5 |
| Smokers |
38.5 |
31.1 |
0.4 |
| Metformin User |
4.3 |
8.2 |
0.31 |
| ASA User |
24.8 |
37.7 |
0.08 |
| Prednisone User |
0.08 |
5 |
0.12 |
| Calcium Channel Block Users |
11.1 |
11.5 |
1 |
| Cox-2 Inhibitor |
0.08 |
7 |
0.05 |
| Statin User |
22.2 |
27.8 |
0.46 |
| Vitamin D User |
10.3 |
50.8 |
<0.0001 |
| Vitamin C User |
1.7 |
14.7 |
0.001 |
| Vitamin B User |
5.2 |
9.8 |
0.34 |
| Folate User |
1.7 |
4.9 |
0.34 |
| Chromium User |
1 |
1.6 |
1 |
| Cinnamon User |
1 |
3.3 |
0.27 |
| Glucosamine User |
2.6 |
11.5 |
0.03 |
| Calcium User |
3.4 |
29.5 |
<0.001 |
| Omega-3 User |
7.6 |
21.3 |
0.01 |
| Zinc User |
0 |
4.9 |
0.04 |
| Supplements other than MVT |
25 |
75.4 |
<0.001 |
|
